Cargando…
Dietary ω-3 Fatty Acid Supplementation Improves Murine Sickle Cell Bone Disease and Reprograms Adipogenesis
Sickle cell disease (SCD) is a genetic disorder of hemoglobin, leading to chronic hemolytic anemia and multiple organ damage. Among chronic organ complications, sickle cell bone disease (SBD) has a very high prevalence, resulting in long-term disability, chronic pain and fractures. Here, we evaluate...
Autores principales: | Valenti, Maria Teresa, Mattè, Alessandro, Federti, Enrica, Puder, Mark, Anez-Bustillos, Lorenzo, Deiana, Michela, Cheri, Samuele, Minoia, Arianna, Brugnara, Carlo, Di Paolo, Maria Luisa, Dalle Carbonare, Luca, De Franceschi, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158389/ https://www.ncbi.nlm.nih.gov/pubmed/34070133 http://dx.doi.org/10.3390/antiox10050799 |
Ejemplares similares
-
Methylsulfonylmethane enhances MSC chondrogenic commitment and promotes pre-osteoblasts formation
por: Carbonare, Luca Dalle, et al.
Publicado: (2021) -
New Therapeutic Options for the Treatment of Sickle Cell Disease
por: Matte, Alessandro, et al.
Publicado: (2019) -
Effects of Oral Anticoagulant Therapy on Gene Expression in Crosstalk between Osteogenic Progenitor Cells and Endothelial Cells
por: Dalle Carbonare, Luca, et al.
Publicado: (2019) -
Clodronate as a Therapeutic Strategy against Osteoarthritis
por: Valenti, Maria Teresa, et al.
Publicado: (2017) -
Physical Activity Modulates miRNAs Levels and Enhances MYOD Expression in Myoblasts
por: Dalle Carbonare, Luca, et al.
Publicado: (2022)